Canadian Imperial Bank (CM) Expected to Beat Earnings Estimates: Should You Buy?
https://www.zacks.com/stock/news/2230247/canadian-imperial-bank-cm-expected-to-beat-earnings-estimates-should-you-buy?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2230247
Feb 22, 2024 - Canadian Imperial Bank (CM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
0
Bank of NT Butterfield & Son (NTB) Beats Q4 Earnings and Revenue Estimates
https://www.zacks.com/stock/news/2225111/bank-of-nt-butterfield-son-ntb-beats-q4-earnings-and-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2225111
Feb 12, 2024 - Bank of NT Butterfield & Son (NTB) delivered earnings and revenue surprises of 3.60% and 4.18%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
0
Barclays' (BCS) Restructuring Aids Amid Revenue Volatility
https://www.zacks.com/stock/news/2224213/barclays-bcs-restructuring-aids-amid-revenue-volatility?cid=CS-ZC-FT-analyst_blog|zer_report_update-2224213
Feb 09, 2024 - Barclays (BCS) faces challenges with volatility in revenue generation amid the economic slowdown, while business restructuring initiatives continue to support financials.
0
CMS Energy Lifts FY24 Earnings Outlook, Dividend; Backs Long-term View; Stock Up In Pre-market
https://www.rttnews.com/story.aspx?Id=3421240
Feb 01, 2024 - CMS Energy Corp. (CMS), while reporting higher fourth-quarter profit, above market estimates, on Thursday raised fiscal 2024 adjusted earnings view, as well as dividend.
0
CMS awards ICF $33M digital modernization contract
https://seekingalpha.com/news/4060293-cms-awards-icf-33m-digital-modernization-contract?source=feed_sector_healthcare
Jan 30, 2024 - ICF has been awarded a $33 million recompete contract by HHS to modernize CMS for kidney dialysis data, ensuring improved healthcare services.
0
CMS Energy (CMS) to Report Q4 Earnings: What's in the Cards?
https://www.zacks.com/stock/news/2217323/cms-energy-cms-to-report-q4-earnings-what-s-in-the-cards?cid=CS-ZC-FT-analyst_blog|earnings_preview-2217323
Jan 29, 2024 - CMS Energy's (CMS) fourth-quarter earnings are likely to have benefited from favorable rate hikes in the prior quarters and cost-reduction initiatives.
0
CMS Energy (CMS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
https://www.zacks.com/stock/news/2215855/cms-energy-cms-earnings-expected-to-grow-what-to-know-ahead-of-next-week-s-release?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2215855
Jan 25, 2024 - CMS Energy (CMS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
0
Best Momentum Stocks to Buy for January 24th
https://www.zacks.com/commentary/2214688/best-momentum-stocks-to-buy-for-january-24th?cid=CS-ZC-FT-zacks_1_rank_additions|momentum_additions-2214688
Jan 24, 2024 - ADMA, CM and HEAR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 24, 2023.
0
BridgeBio Phase 3 data for ATTR-CM drug published in NEJM
https://seekingalpha.com/news/4054421-bridgebio-phase-3-data-for-attr-cm-drug-published-in-nejm?source=feed_sector_healthcare
Jan 11, 2024 - BridgeBio Pharma (BBIO) said positive results from a Phase 3 study for its ATTR-CM drug candidate acoramidis have been published in the New England Journal of Medicine. Read more.
0
CMS Energy (CMS) Commences Operations at 201MW Wind Farm
https://www.zacks.com/stock/news/2204861/cms-energy-cms-commences-operations-at-201mw-wind-farm?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2204861
Jan 03, 2024 - CMS Energy (CMS), with its newly operational wind farm, continues to progress toward its clean energy goals.
0
<Page 2